Blood Cell Separator

Blood Cell Separator Market Outlook

The global blood cell separator market is projected to reach USD 1.8 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2035. This growth is driven by the rising incidence of blood disorders, increasing demand for blood transfusions, and advancements in technology that improve separation techniques. The growing emphasis on research and development in the fields of hematology and oncology also fuels the market expansion. Moreover, an increase in the number of blood donation campaigns and public awareness regarding the importance of blood donation further supports market growth. The expansion of healthcare infrastructure and the rising number of blood banks globally also play significant roles in the market's progression.

Growth Factor of the Market

Several factors drive the growth of the blood cell separator market. Firstly, the increasing prevalence of chronic diseases such as cancer and blood disorders necessitates advanced techniques for effective diagnosis and treatment, which blood cell separators facilitate. Secondly, the technological advancements in blood separation methods, including the rise of microfluidic and acoustic wave-based technologies, enhance the efficiency and accuracy of the separation process, making these devices more appealing to healthcare providers. Additionally, the growing number of research initiatives aimed at understanding blood-related diseases has spurred demand for blood cell separators in research institutions and laboratories. The increase in surgical procedures requiring blood transfusions further contributes to the market's demand. Furthermore, collaborations between healthcare providers and blood banks to enhance blood collection and separation processes have also boosted the market.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 6.5% between 2025 and 2035.
• Technological advancements are leading to the development of more efficient blood separation methods.
• Increasing prevalence of blood-related diseases is driving the demand for blood cell separators.
• The need for effective blood management systems is promoting the expansion of the market.
• Research and development initiatives in hematology are significantly influencing market growth.

By Product Type

Centrifuge-based Cell Separator

Centrifuge-based cell separators utilize centrifugal force to isolate different blood components effectively. These devices are widely used in blood banks and hospitals due to their reliability and efficiency in separating red blood cells, platelets, and plasma. Centrifuge-based systems are equipped with advanced technology to ensure optimal separation with minimal contamination. The ongoing advancements in this sector, such as the development of automated systems that enhance throughput and reduce human error, further benefit the growth of this product type. This segment is anticipated to hold a significant share in the market owing to its established presence and proven efficacy in clinical applications.

Microfluidic-based Cell Separator

Microfluidic-based cell separators are an innovative technology that enables the separation of blood cells at a microscale. These systems utilize small channels to manipulate fluid flow, allowing for precise separation of different cell types. Their advantages include reduced processing times, lower sample volumes, and higher purity of the separated cells. This technology is particularly useful in research settings, such as stem cell research and cancer diagnostics, where high specificity and cell viability are crucial. The growing interest in point-of-care diagnostics is expected to drive the microfluidic segment's growth, as these devices can be integrated into portable platforms.

Filtration-based Cell Separator

Filtration-based cell separation methods rely on the physical properties of cells to separate them from the blood. These methods are characterized by their simplicity and ease of use, making them suitable for various applications, including routine blood processing in hospitals and blood banks. Filtration systems can effectively isolate specific cell types based on size and deformability, offering a straightforward solution for blood component separation. The continued development of microfiltration and ultrafiltration techniques is anticipated to enhance the efficiency and effectiveness of this method, driving its adoption in clinical and research laboratories.

Magnetic Cell Separator

Magnetic cell separators utilize magnetic fields to isolate specific cell populations from blood samples. This technology is particularly effective in the separation of stem cells and other target cell types marked with magnetic beads. Magnetic separation offers several advantages, including high specificity and the ability to process large volumes of blood with minimal impact on cell viability. As the demand for personalized medicine and targeted therapies increases, the magnetic cell separator market is expected to see robust growth, particularly in research applications where the isolation of specific cell types is critical.

Acoustic Wave-based Cell Separator

Acoustic wave-based cell separators represent a novel approach to blood cell separation, leveraging sound waves to manipulate and separate cells from the blood matrix. This method offers several advantages, such as gentle separation that maintains cell integrity, making it particularly suitable for sensitive applications like stem cell extraction. Acoustic separation technology is still in its nascent stages but holds significant potential due to its ability to facilitate high-throughput cell processing without the need for complex setups. As research institutions continue to explore innovative cell separation techniques, this product type is likely to gain traction and contribute to market growth.

By Application

Cancer Research

Cancer research is one of the most significant applications of blood cell separators, as isolating specific blood cells is critical for studying tumor biology and developing targeted therapies. The ability to separate and analyze diverse blood components, including circulating tumor cells (CTCs) and immune cells, enhances the understanding of cancer progression and treatment responses. The increasing focus on personalized medicine and immunotherapy is driving the demand for advanced blood cell separation technologies within this research segment. As the oncology field continues to evolve, the need for efficient and reliable blood cell separators in cancer research will remain a key driver of market growth.

Stem Cell Research

Stem cell research is another critical application area for blood cell separators, as the isolation and characterization of stem cells from peripheral blood or bone marrow are essential for regenerative medicine and therapeutic applications. Blood cell separators facilitate the procurement of hematopoietic stem cells, which are crucial for various transplantation procedures. The growing interest in cell therapy and regenerative medicine is expected to propel the demand for blood cell separators specifically tailored for stem cell isolation. Furthermore, advancements in separation technologies that enhance the yield and viability of isolated stem cells are likely to support the growth of this segment.

Immunology

In the field of immunology, blood cell separators play a vital role in the isolation of immune cells for research and therapeutic purposes. The ability to effectively separate various types of white blood cells, including lymphocytes, monocytes, and dendritic cells, is fundamental for studying immune responses and developing immunotherapies. As the demand for immunological research continues to rise, particularly in the context of autoimmune diseases and vaccine development, the need for specialized blood cell separators will grow correspondingly. The integration of these devices into immunological studies enhances researchers' capabilities to understand complex immune interactions and responses.

Hematology

The hematology application segment benefits significantly from blood cell separators, as these devices are crucial for diagnosing and monitoring blood disorders. The ability to effectively separate and analyze components such as red blood cells, white blood cells, and platelets aids in the assessment of various hematological conditions, including anemia, leukemia, and thrombocytopenia. The increasing prevalence of these disorders and advancements in laboratory practices are expected to drive the demand for blood cell separators in hematology. Moreover, the integration of blood cell separators into automated laboratory workflows enhances efficiency and accuracy in routine blood analysis.

Others

The "Others" application category encompasses a diverse range of uses for blood cell separators, including applications in clinical trials, biobanking, and various research fields. As the versatility of blood cell separation technologies continues to be recognized, this segment is expected to witness growth across multiple sectors. The development of customized solutions that cater to specific research needs will further enhance the adoption of blood cell separators in various applications. The ongoing exploration of novel uses for these devices in emerging fields will also contribute to the expansion of the blood cell separator market overall.

By End User

Hospitals

Hospitals are among the primary end-users of blood cell separators, employing these devices for various clinical and diagnostic purposes. The need for efficient blood component separation in transfusion practices, surgical procedures, and laboratory diagnostics drives the demand for blood cell separators in healthcare institutions. Hospitals are increasingly adopting advanced separation technologies to improve patient outcomes and streamline operations. The ongoing investments in healthcare infrastructure and the expansion of specialized treatment centers will likely enhance the growth of this segment as hospitals continue to integrate innovative blood processing technologies into their workflows.

Research Institutes

Research institutes play a pivotal role in the blood cell separator market, utilizing these devices for fundamental and applied research in hematology, oncology, and immunology. The ability to isolate specific cell populations is crucial for experimental studies and the development of new therapies. As research funding and initiatives continue to expand, the demand for advanced blood cell separation technologies in academic and private research settings is expected to grow. The collaboration between research institutions and industry players to develop cutting-edge separation techniques will also contribute to the advancement of this segment.

Blood Banks

Blood banks are significant consumers of blood cell separators, as these devices are essential for the efficient collection, processing, and storage of blood components. The rising demand for blood transfusions and the need for high-quality blood products are driving the growth of blood banks globally. Advanced blood cell separators allow for the optimal separation of red blood cells, platelets, and plasma, ensuring that blood banks can provide safe and effective products to healthcare providers. As the blood donation rates increase and the importance of maintaining a stable blood supply is emphasized, blood banks will continue to invest in sophisticated separation technologies.

Pharmaceutical & Biotechnology Companies

Pharmaceutical and biotechnology companies utilize blood cell separators primarily for research and development purposes, especially in the context of drug discovery and development. The ability to isolate specific cell types for testing therapeutic candidates and understanding disease mechanisms is vital for these organizations. As the pharmaceutical industry increasingly focuses on personalized medicine and targeted therapies, the demand for blood cell separators tailored to specific research needs will continue to grow. Collaboration between academia and industry to develop innovative solutions for drug development and therapeutic applications will further propel this segment's expansion.

Others

The "Others" end-user category includes various entities such as diagnostic laboratories, biobanks, and contract research organizations (CROs) that utilize blood cell separators for diverse applications. These organizations often require versatile and efficient separation technologies to meet their specific needs. The ongoing development of customized solutions that cater to different industry requirements will drive growth within this segment. As the importance of blood cell separation is recognized across various sectors, the demand for these devices in non-traditional applications is expected to increase, contributing to the overall market expansion.

By Cell Type

Red Blood Cells

Red blood cells (RBCs) are the most abundant cells in blood and play a critical role in oxygen transport throughout the body. Blood cell separators specifically designed for isolating RBCs are essential for various applications, including transfusions, research, and clinical studies. Efficient separation techniques ensure that RBCs retain their functionality and viability, making them suitable for transfusion purposes. The increasing prevalence of conditions such as anemia and the growing demand for blood transfusions in surgical procedures are expected to drive the demand for RBC separation technologies, highlighting the importance of this segment in the blood cell separator market.

White Blood Cells

White blood cells (WBCs) are vital components of the immune system and are critical for combating infections and diseases. The separation of WBCs is essential for immunological studies and the diagnosis of various hematological disorders. Blood cell separators that focus on WBC isolation enable researchers and clinicians to analyze immune responses and develop targeted therapies. The growing interest in immunotherapy and precision medicine is anticipated to drive the demand for WBC separation technologies, as understanding the immune landscape is crucial for effective treatment strategies. As the importance of immune cells in disease management is recognized, the market for WBC separators is expected to expand.

Platelets

Platelets play a crucial role in blood clotting and wound healing, making their separation essential in various clinical settings, including surgeries and trauma care. Blood cell separators designed for platelet isolation are widely used in hospitals and blood banks to provide high-quality platelet products for transfusions. The increasing prevalence of bleeding disorders and the demand for platelet-rich plasma therapies are expected to drive the market for platelet separation technologies. Furthermore, advancements in separation methods that enhance platelet recovery and functionality will likely contribute to the growth of this segment, ensuring that patients receive optimal care.

Stem Cells

Stem cells are unique cells with the ability to differentiate into various cell types, making them highly valuable for regenerative medicine and transplantation. The ability to isolate stem cells from blood or bone marrow is critical for research and therapy applications, including hematopoietic stem cell transplantation. Blood cell separators that focus on stem cell isolation utilize advanced techniques to ensure high purity and viability of the isolated cells. The growing interest in regenerative medicine and cell therapy is expected to significantly propel the demand for stem cell separation technologies. As research in this area continues to advance, the importance of efficient stem cell separators will become increasingly evident.

Others

The "Others" cell type category encompasses various specialized cells that may require separation, such as progenitor cells and specific immune cell subsets. The demand for separation technologies catering to these unique cell types is growing as researchers explore novel therapeutic strategies and study complex biological processes. The ongoing advancements in blood cell separator technologies that offer flexibility and customization for isolating diverse cell types will contribute to the growth of this segment. As research in cellular biology expands, the need for sophisticated separation methods tailored to specific cell populations will play a significant role in the overall market development.

By Region

The North American blood cell separator market is projected to dominate the global landscape, accounting for approximately 38% of the total market share by 2035. Factors contributing to this dominance include advanced healthcare infrastructure, significant investments in research and development, and a high prevalence of blood disorders requiring effective separation techniques. The presence of key market players and a well-established regulatory framework further enhance market growth in this region. North America is expected to experience a CAGR of 7% during the forecast period, driven by technological advancements and increased demand for blood component therapies.

In Europe, the blood cell separator market is anticipated to grow at a CAGR of 5.5% from 2025 to 2035, accounting for approximately 30% of the global market by 2035. The growth in this region is fueled by rising investments in healthcare and research initiatives focusing on cancer and hematological disorders. Additionally, the increasing number of blood donation campaigns and awareness programs regarding blood transfusions contribute to market growth. The presence of well-established blood banks and research institutions further supports the expansion of the blood cell separator market in Europe, as these entities continuously seek advanced technologies for blood processing.

Opportunities

The blood cell separator market is ripe with opportunities driven by advancements in technology and increasing healthcare demands. The rise of personalized medicine and targeted therapies creates a significant opportunity for innovative blood cell separator solutions tailored to meet specific patient needs. Companies that invest in research and development to create cutting-edge technologies, such as microfluidic and acoustic wave-based systems, can capture a substantial market share. Moreover, as the emphasis on regenerative medicine and cell therapies continues to grow, blood cell separators will play a pivotal role in isolating and characterizing stem cells and other regenerative cell types, presenting lucrative opportunities for market players.

Another avenue for growth lies in the emerging markets of Asia Pacific and Latin America, where increasing healthcare investments and improving infrastructure are fostering the demand for modern medical devices, including blood cell separators. The rise in blood donation rates and the establishment of advanced blood processing facilities in these regions create a favorable landscape for market expansion. Companies targeting these markets with cost-effective and efficient separation technologies can gain a competitive edge. Furthermore, collaborations with local healthcare providers and research institutions to tailor solutions to regional needs will enhance market penetration and overall growth.

Threats

Despite the promising growth prospects, the blood cell separator market faces several threats that could impede its expansion. One of the primary concerns is the stringent regulatory environment surrounding medical devices, which can delay product approvals and increase compliance costs for manufacturers. The evolving regulatory landscape may pose challenges for new entrants and established players alike, potentially impacting their ability to innovate and bring products to market promptly. Additionally, the presence of well-established competitors and the rapid pace of technological advancements in the industry can create a highly competitive atmosphere, making it difficult for smaller companies to maintain market share.

Moreover, the ongoing economic uncertainties and fluctuating healthcare budgets in various regions can hinder investment in advanced medical technologies, including blood cell separators. Budget constraints faced by healthcare institutions may lead to a preference for traditional separation methods over newer, more sophisticated technologies. This reluctance to invest in upgrades can stagnate market growth and limit the adoption of innovative solutions. Manufacturers will need to navigate these challenges effectively and develop strategies that emphasize the value and efficiency of their products to sustain growth in this dynamic market.

Competitor Outlook

• Thermo Fisher Scientific
• Fresenius Kabi AG
• Haemonetics Corporation
• Beckman Coulter, Inc.
• Terumo BCT, Inc.
• Macopharma
• Greiner Bio-One GmbH
• Sysmex Corporation
• Miltenyi Biotec
• Cerus Corporation
• Bio-Rad Laboratories, Inc.
• Asahi Kasei Medical Co., Ltd.
• CellGenix GmbH
• STEMCELL Technologies Inc.
• GRAHAM Medical & Scientific

The competitive landscape of the blood cell separator market is characterized by a mix of established players and innovative startups focusing on advanced separation technologies. Key market players are continuously investing in research and development to enhance their product offerings and meet the evolving needs of healthcare providers. Collaborations and partnerships among companies, research institutions, and healthcare facilities are becoming increasingly common, as stakeholders seek to leverage each other's strengths to drive innovation and improve product efficacy. Furthermore, the focus on regulatory compliance and quality assurance is paramount for companies aiming to succeed in this highly regulated industry.

Thermo Fisher Scientific stands out as a global leader in the blood cell separator market, offering a comprehensive portfolio of products designed for various applications, including research and clinical diagnostics. Their commitment to innovation and quality has positioned them as a preferred choice among healthcare providers and researchers. Similarly, Fresenius Kabi AG has established a strong presence in the market with its advanced blood component separation technologies, focusing on enhancing patient outcomes and ensuring safe blood transfusions. The company's dedication to research and development, coupled with its extensive distribution network, enables it to cater to diverse customer needs effectively.

Haemonetics Corporation is another significant player in the blood cell separator market, specializing in blood component collection and processing solutions. Their innovative technologies, such as automated blood collection systems, have garnered widespread adoption in hospitals and blood banks. Additionally, companies like Beckman Coulter and Terumo BCT are investing heavily in developing next-generation separators that leverage cutting-edge technologies, such as microfluidics and acoustic separation methods. This emphasis on technological advancement, combined with a customer-centric approach, positions these companies competitively in the rapidly evolving blood cell separator market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Macopharma
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 CellGenix GmbH
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Miltenyi Biotec
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Terumo BCT, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cerus Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Sysmex Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Greiner Bio-One GmbH
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Beckman Coulter, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Haemonetics Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Thermo Fisher Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 STEMCELL Technologies Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 GRAHAM Medical & Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Asahi Kasei Medical Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Cell Separator Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Research Institutes
    • 6.1.3 Blood Banks
    • 6.1.4 Pharmaceutical & Biotechnology Companies
    • 6.1.5 Others
  • 6.2 Blood Cell Separator Market, By Cell Type
    • 6.2.1 Red Blood Cells
    • 6.2.2 White Blood Cells
    • 6.2.3 Platelets
    • 6.2.4 Stem Cells
    • 6.2.5 Others
  • 6.3 Blood Cell Separator Market, By Application
    • 6.3.1 Cancer Research
    • 6.3.2 Stem Cell Research
    • 6.3.3 Immunology
    • 6.3.4 Hematology
    • 6.3.5 Others
  • 6.4 Blood Cell Separator Market, By Product Type
    • 6.4.1 Centrifuge-based Cell Separator
    • 6.4.2 Microfluidic-based Cell Separator
    • 6.4.3 Filtration-based Cell Separator
    • 6.4.4 Magnetic Cell Separator
    • 6.4.5 Acoustic Wave-based Cell Separator

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Blood Cell Separator Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Cell Separator market is categorized based on

By Product Type

• Centrifuge-based Cell Separator
• Microfluidic-based Cell Separator
• Filtration-based Cell Separator
• Magnetic Cell Separator
• Acoustic Wave-based Cell Separator

By Application

• Cancer Research
• Stem Cell Research
• Immunology
• Hematology
• Others

By End User

• Hospitals
• Research Institutes
• Blood Banks
• Pharmaceutical & Biotechnology Companies
• Others

By Cell Type

• Red Blood Cells
• White Blood Cells
• Platelets
• Stem Cells
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Fresenius Kabi AG
• Haemonetics Corporation
• Beckman Coulter, Inc.
• Terumo BCT, Inc.
• Macopharma
• Greiner Bio-One GmbH
• Sysmex Corporation
• Miltenyi Biotec
• Cerus Corporation
• Bio-Rad Laboratories, Inc.
• Asahi Kasei Medical Co., Ltd.
• CellGenix GmbH
• STEMCELL Technologies Inc.
• GRAHAM Medical & Scientific